A plantibody (derived from
Plant and
antibody) is a special type of
antibody created from genetically altered crops. The term plantibody as well as the concept is trademarked by the company
Biolex. The term was first cited in 1989 referring to an antibody produced by introducing antibody genes (from mice or humans) into a plant through a process called genetic
transformation. Although plants do not have an immune system of their own, and do not normally make antibodies, plantibodies have been shown to function in the same way as normal antibodies. A number of companies in addition to Biolex, including Planet Biotechnology in California, and Medicago in Canada are pursuing the commercial development of plantibodies as therapies for everything from cancer to the common cold. A number of plant species are being experimented with in the production and cultivation of plantibodies.
See more at Wikipedia.org...
antibody produced by a genetically modified plant, a trademark of Epicyte Pharmaceutical Inc.